The Enterprise Value as of November 2024 (TTM) for Repligen Corporation (RGEN) is 7.88B

According to Repligen Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 7.88B. This represents a change of -10.52% compared to the average of 8.80B of the last 4 quarters.

Repligen Corporation (RGEN) Historical Enterprise Value (quarterly & annually)

How has RGEN Enterprise Value performed in the past?

The mean historical Enterprise Value of Repligen Corporation over the last ten years is 5.34B. The current 7.88B Enterprise Value has changed 14.65% with respect to the historical average. Over the past ten years (40 quarters), RGEN's Enterprise Value was at its highest in in the September 2021 quarter at 15.59B. The Enterprise Value was at its lowest in in the December 2014 quarter at 586.38M.

Repligen Corporation (RGEN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Repligen Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Repligen Corporation (RGEN) Average Enterprise Value

How has RGEN Enterprise Value performed in the past?

The current Enterprise Value of Repligen Corporation (RGEN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Repligen Corporation (RGEN) Enterprise Value vs. Peers

How is RGEN’s Enterprise Value compared to its peers?

Repligen Corporation’s Enterprise Value is less than Intuitive Surgical, Inc. (192.73B), less than ResMed Inc. (36.21B), greater than Merit Medical Systems, Inc. (6.43B), greater than ICU Medical, Inc. (5.41B), less than The Cooper Companies, Inc. (22.60B), less than West Pharmaceutical Services, Inc. (22.74B), less than Becton, Dickinson and Company (81.77B), less than Hologic, Inc. (18.72B), less than Teleflex Incorporated (10.52B), greater than Haemonetics Corporation (5.22B), greater than AngioDynamics, Inc. (227.33M), less than AptarGroup, Inc. (12.22B), greater than Envista Holdings Corporation (4.28B),

Build a custom stock screener for Repligen Corporation (RGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Repligen Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Repligen Corporation (RGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Repligen Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.